Your browser doesn't support javascript.
loading
Examining a staging model for anorexia nervosa: empirical exploration of a four stage model of severity.
Maguire, Sarah; Surgenor, Lois J; Le Grange, Daniel; Lacey, Hubert; Crosby, Ross D; Engel, Scott G; Fromholtz, Kirsty M; Bamford, Bryony; Touyz, Stephen.
Afiliación
  • Maguire S; Centre for Eating and Dieting Disorders, University of Sydney, Sydney, Australia.
  • Surgenor LJ; Department of Psychological Medicine, University of Otago at Christchurch, Christchurch, New Zealand.
  • Le Grange D; Department of Psychiatry, University of California, Christchurch, USA.
  • Lacey H; St Georges University of London, Eating Disorders Research Group, London, UK.
  • Crosby RD; Neuropsychiatric Research Institute, School of Medicine and Health Sciences, University of North Dakota, Fargo, North Dakota USA.
  • Engel SG; Neuropsychiatric Research Institute, School of Medicine and Health Sciences, University of North Dakota, Fargo, North Dakota USA.
  • Fromholtz KM; Centre for Eating and Dieting Disorders, University of Sydney, Sydney, Australia.
  • Bamford B; The London Centre for Eating Disorders and Body Image, London, UK.
  • Touyz S; School of Psychology, University of Sydney, Sydney, Australia.
J Eat Disord ; 5: 41, 2017.
Article en En | MEDLINE | ID: mdl-29209500
BACKGROUND: An illness staging model for anorexia nervosa (AN) has received increasing attention, but assessing the merits of this concept is dependent on empirically examining a model in clinical samples. Building on preliminary findings regarding the reliability and validity of the Clinician Administered Staging Instrument for Anorexia Nervosa (CASIAN), the current study explores operationalising CASIAN severity scores into stages and assesses their relationship with other clinical features. METHOD: In women with DSM-IV-R AN and sub-threshold AN (all met AN criteria using DSM 5), receiver operating curve (ROC) analysis (n = 67) assessed the relationship between the sensitivity and specificity of each stage of the CASIAN. Thereafter chi-square and post-hoc adjusted residual analysis provided a preliminary assessment of the validity of the stages comparing the relationship between stage and treatment intensity and AN sub-types, and explored movement between stages after six months (Time 3) in a larger cohort (n = 171). RESULTS: The CASIAN significantly distinguished between milder stages of illness (Stage 1 and 2) versus more severe stages of illness (Stages 3 and 4), and approached statistical significance in distinguishing each of the four stages from one other. CASIAN Stages were significantly associated with treatment modality and primary diagnosis, and CASIAN Stage at Time 1 was significantly associated with Stage at 6 month follow-up. CONCLUSIONS: Provisional support is provided for a staging model in AN. Larger studies with longer follow-up of cases are now needed to replicate and extend these findings and evaluate the overall utility of staging as well as optimal staging models.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Eat Disord Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Eat Disord Año: 2017 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido